Mitral Valve Tissue Plication Anchor Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Mitral regurgitation, characterized by the backflow of blood due to incomplete closure of the mitral valve, poses significant risks for patients undergoing surgical correction, necessitating a less invasive solution.
Innovation Solution
Deployment of tissue fixation devices, or anchors, within the mitral valve annulus to reduce annular circumference and modify the valve's geometry, facilitating leaflet coaptation without the need for open heart surgery, using a combination of semi-rigid bars, fabric ribbons, and sutures to tension and secure the anchors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional surgical correction is performed to fix mitral regurgitation, then valve function is restored, but patient risk increases due to open heart surgery
Solution Approach 1:
The patent replaces open heart surgery with a percutaneous delivery system that uses a catheter to transport the plication device through the blood vessels to the mitral valve annulus, eliminating the need for thoracic surgery while achieving the same functional outcome
Solution Approach 2:
The patent introduces a delivery catheter as an intermediary tool to transport the plication device from the percutaneous access site to the target location at the mitral valve annulus, enabling minimally invasive placement without direct surgical exposure
2Object-affected harmful factors
If percutaneous delivery is used to avoid open heart surgery, then surgical risk is reduced, but device complexity increases
Solution Approach 1:
The patent divides the device into separate functional components: a plication element for valve modification, a delivery catheter for transport, and a retrieval mechanism for removal, allowing each component to be optimized independently while simplifying the overall system
Solution Approach 2:
The patent employs a self-expanding plication element that transitions from a compressed delivery state within the catheter to an expanded functional state at the valve annulus, enabling simple delivery while achieving complex valve modification
3Reliability
If anchor tensioning is applied to reduce annular circumference, then leaflet coaptation is improved, but tissue damage risk increases
Solution Approach 1:
The patent uses a self-expanding plication element that changes its physical state from compressed during delivery to expanded during deployment, allowing controlled tissue engagement and coaptation while minimizing damage through gradual expansion rather than forceful insertion
Solution Approach 2:
The patent employs a flexible plication element that can conform to the valve annulus geometry while maintaining sufficient rigidity to achieve coaptation, balancing tissue compression with tissue preservation through flexible yet controlled structural design
Data Source
AI summary
A device for treating mitral regurgitation including an anchor which features one or more reinforcing bars, ribbon and suture.


